LCS
EVH icon

Levin Capital Strategies’s Evolent Health EVH Stock Holding History

Levin Capital Strategies’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-59,000
Closed -$664K – 193
2024
Q4 		$664K Buy
+59,000
New +$1.04M 0.06% 109
2020
Q2 		– Sell
-27,132
Closed -$147K – 196
2020
Q1 		$147K Sell
27,132
-10,000
-27% -$89.3K 0.02% 142
2019
Q4 		$336K Sell
37,132
-823,579
-96% -$6.69M 0.03% 137
2019
Q3 		$6.19M Buy
860,711
+261,835
+44% +$1.88M 0.68% 40
2019
Q2 		$4.76M Buy
598,876
+554,876
+1,261% +$6.57M 0.47% 48
2019
Q1 		$554K Buy
+44,000
New +$697K 0.06% 107
2018
Q2 		– Sell
-15,500
Closed -$221K – 312
2018
Q1 		$221K Buy
+15,500
New +$222K ﹤0.01% 265
2017
Q4 		– Sell
-42,000
Closed -$748K – 327
2017
Q3 		$748K Buy
+42,000
New +$865K 0.01% 167

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Levin Capital Strategies's EVH Position: Q1 2025 in Review

Levin Capital Strategies sold out of Evolent Health (EVH) in Q1 2025, closing a stake of 59,000 shares — an estimated $664K sold.

Levin Capital Strategies first reported a position in EVH in Q3 2017 and held it in 8 quarters. The position peaked at $6.19M in Q3 2019. 227 funds tracked by Wall St. Rank hold EVH as of Q1 2025.

  • Levin Capital Strategies reported no remaining Evolent Health position as of Q1 2025 after selling out during the quarter.
  • Levin Capital Strategies sold 59,000 Evolent Health shares in Q1 2025, an estimated $664K.
  • Levin Capital Strategies first reported a position in Evolent Health in Q3 2017 and held it in 8 quarters.
  • Levin Capital Strategies's Evolent Health position peaked at $6.19M in Q3 2019.
  • 227 funds tracked by Wall St. Rank held Evolent Health as of Q1 2025.

Based on Levin Capital Strategies's 13F filing for Q1 2025, filed 9 May 2025.